SEER, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- SEER, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 20.81K shares.
- SEER, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 8.05K shares.
- SEER, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 5.95K shares.
- SEER, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 11.67K shares.
- SEER, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 28.67K shares, a 340.93% increase from fiscal 2024.
- SEER, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 6.50K shares, a 96.56% decline from fiscal 2023.
- SEER, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 189.00K shares, a 80.60% decline from fiscal 2022.
- SEER, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 974.31K shares, a 6.36% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 20.81K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | 46.48K shares derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | 8.05K shares 10-Q · filed 2026-05-13 | |
| 2025-12-31 | 5.95K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | 28.67K shares 10-K · filed 2026-03-02 |
| 2025-09-30 | 11.67K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | 6.50K shares 10-K · filed 2025-03-03 |
| 2024-03-31 | 0.00 shares 10-Q · filed 2024-05-08 | 175.40K shares derived: sum of 4 quarters · filed 2024-05-08 |
| 2023-12-31 | 151.76K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-04 | 189.00K shares 10-K · filed 2024-03-04 |
| 2023-09-30 | 14.07K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | 704.69K shares derived: sum of 4 quarters · filed 2023-11-07 |
| 2023-06-30 | 9.57K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | 715.64K shares derived: sum of 4 quarters · filed 2023-08-08 |
| 2023-03-31 | 13.60K shares 10-Q · filed 2023-05-09 | 793.70K shares derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-12-31 | 667.45K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | 974.31K shares 10-K · filed 2023-03-06 |
| 2022-09-30 | 25.03K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | 586.99K shares derived: sum of 4 quarters · filed 2022-11-08 |
| 2022-06-30 | 87.62K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | 792.16K shares derived: sum of 4 quarters · filed 2022-08-09 |
| 2022-03-31 | 194.21K shares 10-Q · filed 2022-05-06 | 835.55K shares derived: sum of 4 quarters · filed 2022-05-06 |
| 2021-12-31 | 280.13K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 1.04M shares 10-K · filed 2022-03-01 |
| 2021-09-30 | 230.21K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | |
| 2021-06-30 | 131.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | |
| 2021-03-31 | 399.17K shares 10-Q · filed 2021-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |